NRP1 and glioblastoma: This transmembrane receptor was suggested as a molecular therapeutic target for GBM [6] as its overexpression is mainly due to angiogenic endothelial cells and glioma-associated macrophages (GAM), with both being related to an unfavorable prognosis [7].